Title Znanje studenata sestrinstva o bakteriji Helicobacter pylori Title (english) Knowledge of nursing students on the bacterial agent Helicobacter pylori Author Nikolina Ribić Mentor Tomislav Meštrović (mentor)Committee member Sonja Obranić (predsjednik povjerenstva)Committee member Tomislav Meštrović (član povjerenstva)Committee member Valentina Vincek (član povjerenstva) Granter University North Defense date and country 2023-06-07, Croatia Scientific / art field, BIOMEDICINE AND HEALTHCARE Abstract Helicobacter pylori (H. pylori) je gram-negativna spiralna bakterija koju su 1983. godine otkrili australski liječnici B. Marshall i R. Warren. Za njeno otkriće su 2005. godine dobili Nobelovu nagradu. Bakterija se nastanjuje na sluznici želuca. Infekcija često bude asimptomatska, no mogu se razviti i ozbiljne posljedice kao što su kronični gastritis, ulkus i čirevi, a može doći i do karcinoma želuca. Baš iz tog razloga, važno je potaknuti populaciju na edukaciju o bakteriji H. pylori. Zaraza se može prenijeti: oralno-oralnim putem, feko-oralnim putem, gastro-oralnim putem, preko povraćenog sadržaja, uporabom nedovoljno sterilnih endoskopskih i stomatoloških instrumenata ili kontaminiranom hranom i pićem. Dijagnostika infekcije može biti invazivna i neinvazivna. U invazivne metode spadaju: ezofagogastroduodenoskopije s biposijom za patohistološku analizu, brzo ispitivanje ureaze, molekularne metode i kultura H. pylori. Neinvazivne metode uključuju urea izdisajni test, detekciju antigena u stolici te serološko ispitivanje. Nakon dokazivanja infekcije, liječenje započinje prvom linijom kombinirane trojne terapije koja se sastoji od inhibitora protonske pumpe i dva antibiotika.
Cilj ovog rada bio je uvidjeti znanje studenata sestrinstva o bakteriji H. pylori s obzirom na to da je infekcija s H. pylori učestala diljem svijeta. Ukupno 86,7% studenata sestrinstva susrelo se s pojmom infekcije bakterijom H. pylori. Manje od 50% ispitanika je znalo da je Helicobacter pylori gram negativna bakterija, samo 47,8%. Da se infekcija s H. pylori liječi antibioticima uz inhibitore protonske pumpe, znalo je 59,3% studenata.
Abstract (english) Helicobacter pylori (H. pylori) is a gram-negative spiral bacterium that was discovered in 1983 by Australian doctors B. Marshall and R. Warren. In 2005, they received the Nobel Prize for its discovery. The bacterium lives on the lining of the stomach. The infection is often asymptomatic, but serious consequences such as chronic gastritis, ulcers and ulcers can develop, even stomach cancer can also occur. Because of that, it is important to encourage the population to educate themselves about the H. pylori bacteria. The infection can be transmitted: oral-oral, feco-oral, gastro-oral, vomited contents, use of insufficiently sterile endoscopic and dental instruments or contaminated food and drink. Diagnosis of infection can be invasive or non-invasive. Invasive methods include: esophagogastroduodenoscopy with biopsy for pathohistological analysis, rapid urease testing, molecular methods and H. pylori culture. Non-invasive methods include urea breath test, antigen detection in stool and serological testing. After proof of infection, treatment begins with the first line of combined triple therapy consisting of a proton pump inhibitor and two antibiotics.
The aim of this work was to find out the knowledge of nursing students about the H. pylori bacterium, given that H. pylori infection is common all over the world. A total of 86.7% of nursing students encountered the term H. pylori infection. Less than 50% of respondents knew that Helicobacter pylori is a gram-negative bacterium, only 47.8%. 59.3% of students knew that H. pylori infection is treated with antibiotics along with proton pump inhibitors.
Keywords
bakterija Helicobacter pylori
infekcija
eradikacija
trojna terapija
Keywords (english)
Helicobacter pylori bacteria
infection
eradication
triple therapy
Language croatian URN:NBN urn:nbn:hr:122:440445 Study programme Title: Nursing Type of resource Text File origin Born digital Access conditions Open access Terms of use Created on 2023-07-12 13:13:49
